dupilumab
regeneron,sanofi
['dupilumab', 'sipo']
#dupilumab is a safe and effective option for patients with prurigo nodularis - more evidence and a great talk by dr gil yosipovitch #itch #eadv2022. will a fda-approval follow? 
Physician. Aspiring dermatologist. I collect hobbies, memories and sunscreens. Proud to be a #EADVcongress oficial social media reporter!